IMR Press / EJGO / Volume 28 / Issue 1 / pii/2007104

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Survival of 231 cervical cancer patients, treated by radical hysterectomy, according to clinical and histopathological features

Show Less
1 Department of Gynaecological Endocrinology, Medical University of Gdarisk, Poland
2 INVICTA Laboratory of Molecular Biology, Prophylactic Centre, Gdaris, Poland
3 Department of Oncology and Radiotherapy, Medical University of Gdarisk, Poland
4 Department of Gynaecology, District Hospital of Ilawa, Poland
Eur. J. Gynaecol. Oncol. 2007, 28(1), 23–27;
Published: 10 February 2007

Purpose of investigation: The purpose of the study was to estimate the five-year survival of cervical cancer patients after radical hysterectomy, taking into account clinical data and histopathological parameters. Methods: 231 patients with invasive cervical carcinoma were diagnosed, surgically treated - Piver III - and followed-up. Histological examination of specimens was performed according to the British NHS-CSP guidelines. Results: We discovered no statistical significance as regards age at diagnosis, age at menarche and menopause, and number of pregnancies, deliveries and abortions, in relation to survival. We concluded that the clinical stage according to FIGO classification influenced survival. Statistical significances were: Ia2 vs Ib, Ib vs IIa and IIa vs more advanced than IIa. The following histopatho­logical parameters correlated with survival: depth of cervical invasion, primary lesion volume, and parametrial, uterine, vaginal and lymph node involvement. Using Cox's proportional hazards model we found that only lymph node status and FIGO staging were independent parameters Prognostic corrlating with survival and mortal risk disease in our study. Conclusion: Prognostic indexes classifying patients at specific disease stages into different categories of risk should be based on histopathological features listed above. Such indexes are yet to be validated in larger, prospective studies conducted in different patient populations.

Cervical cancer
Clinical staging
Histopathological parameters
Lymph node metastases
Survival prognosis
Back to top